Resistance to this inhibitory mechanism may contribute to the highly metastatic potential of B16 melanoma.
INTRODUCTION
Various adhesion molecules expressed on the surface of mammalian cells, including members of the integrin receptor and cadherin families and of the immunoglobulin (Ig) 1 superfamily, have been characterized. These proteins are fundamental to cell growth, differentiation, and migration, and their dysregulation has been implicated in the pathogenesis of cancer, inflammation, and neurodegeneration.
SHPS-1, also known as SIRPa1 (1), BIT (2), MFR (3), and p84 neural adhesion molecule (4) , is a transmembrane glycoprotein of the Ig superfamily and is abundant in neural and myeloid tissues (5) (6) (7) . The cytoplasmic region of SHPS-1 contains two immunoreceptor tyrosine-based inhibitory motifs, which bind and activate the Src homology 2 domain-containing protein tyrosine phosphatases SHP-1
and SHP-2 in a phosphorylation-dependent manner (1, 5, 8) . The extracellular region of this protein comprises three Ig-like domains, of which the most amino-terminal, Ig V-like domain associates with the ligand CD47 (9-11).
CD47, which was originally identified in association with avb3 integrin and hence referred to as integrin-associated protein (12) , is also a member of the Ig superfamily, possessing an Ig V-like extracellular domain, five putative membranespanning segments, and a short cytoplasmic tail (11) . CD47 and SHPS-1 appear to constitute a cell-cell communication system (the CD47-SHPS-1 system) that contributes to a variety of physiological processes, including phagocytosis of red blood cells by macrophages (13) , macrophage multinucleation (14) , T cell activation (15, 16) , and neutrophil transmigration (17) .
SHPS-1 negatively or positively regulates intracellular signaling initiated either
by tyrosine kinase-coupled receptors for growth factors or by cell adhesion to extracellular matrix proteins (18, 19) . With the use of mice lacking most of the cytoplasmic region of SHPS-1 (20, 21) , we recently showed that this protein plays an important role both in integrin-mediated cytoskeletal reorganization and in cell migration. In addition, studies with dominant negative or loss-of-function mutant proteins have established SHP-2 as a signaling component essential for cell adhesion and migration as well as cytoskeletal organization (22) (23) (24) (25) (26) . SHPS-1 thus likely promotes cell migration by facilitating regulation of the cytoskeleton by SHP-2 at the by guest on July 15, 2017 http://www.jbc.org/ Downloaded from cell membrane.
Expression of SHPS-1 has been shown to be down-regulated in subsets of human leukemic myeloid cells (10) , human breast cancer tissue (27) , and fibroblasts transformed by various oncogene products (28) . Furthermore, forced expression of SHPS-1 suppressed the transformed phenotype of glioblastoma cells (29) as well as inhibited both anchorage-independent growth of v-Src-transformed cells (28) and peritoneal dissemination of these cells in nude mice (27) . Together, these observations have implicated SHPS-1 in cellular transformation. It has remained unclear, however, whether (and, if so, how) functional alteration of the CD47-SHPS-1 system contributes to carcinogenesis. suggesting that resistance to this inhibitory mechanism might underlie the highly metastatic potential of B16 melanoma. Rabbit polyclonal antibodies to SHP-2 (5) and a rat monoclonal antibody (mAb)
EXPERIMENTAL PROCEDURES
to mouse SHPS-1 (20) were described previously. A rat mAb to CD47 (MIAP301), normal rat IgG, and horseradish peroxidase-conjugated mAb PY20 to phosphotyrosine were obtained from Santa Cruz Biotechnology; rabbit polyclonal antibodies to SHPS-1 and to FAK were from Upstate Biotechnology; a mouse mAb to tubulin was from Sigma; goat antibodies to rat IgG, fluorescein isothiocyanate-conjugated goat antibodies to human IgG, and the Fc fragment of human IgG were from Cappel; Cy2-conjugated goat antibodies to rat IgG were from Amersham Pharmacia Biotech; and goat antibodies to the Fc fragment of human IgG were from Jackson ImmunoResearch.
The mAb 9E10 to the Myc tag and mAb 12CA5 to the HA tag were purified from the culture supernatants of mouse hybridoma cells.
Tunicamycin, 1-deoxymannojirimycin, and chloroquine were purchased from Sigma. MG132 were from Calbiochem. Electrophoresis under nonreducing conditions revealed that SHPS-1 expressed in both cell lines migrated as two major bands (Fig. 1C) . The fastermigrating forms exhibited higher affinity for GNA lectin, which specifically recognizes terminal mannose residues (36), than did the slower-migrating forms ( 
SHPS-1 derived from Melan-a cells, but not that from B16F10 cells, bound
CD47-Fc in vitro (Fig. 3A) . In contrast, SHPS-1 from the two cell lines after treatment with 1-deoxymannojirimycin bound similar amounts of CD47-Fc (Fig. 3B ).
SHPS-1 from both cell lines exposed to tunicamycin also bound CD47-Fc to similar extents (Fig. 3C) . Sequencing of the products generated by reverse transcription and PCR analysis of SHPS-1 mRNA from the two cell lines revealed no differences in the coding sequence for the amino-terminal Ig V-like domain of SHPS-1 (data not shown). Together, these results indicate that the impaired binding of CD47-Fc by B16F10 cells results, at least in part, from aberrant N-glycosylation of SHPS-1. 
Ligation of SHPS-1 Inhibits Cell Migration-To

Binding of CD47 to Cells Down-regulates SHPS-1 Expression-SHPS-1
promotes cell migration by recruiting SHP-2 to the cell membrane and thereby activating its phosphatase activity (20) , suggesting that CD47 binding to cells might inhibit cell motility by abrogating this function of SHPS-1. We observed that the expression level of SHPS-1 in Melan-a cells incubated with CD47-Fc for 6 h was substantially lower than that apparent in cells incubated with the control Fc fragment for a similar period (Fig. 5A, upper panel) . In contrast, the abundance of SHPS-1 in B16F10 cells incubated with CD47-Fc was comparable to that observed for control cells (Fig. 5A, lower panel) . Exposure to CD47-Fc did not substantially affect the expression of tubulin in both cell lines, arguing against a toxic effect of the soluble ligand (Fig. 5A ).
Given that Melan-a cells express both SHPS-1 and CD47 (data not shown), it immunoreactivity on the cell surface as revealed by flow cytometry (Fig. 6A) . They also bound CD47-Fc to similar extents (Fig. 6A) , suggesting that cytoplasmic tyrosine residues of SHPS-1 do not play an important role in the interaction with CD47.
Expression of the SHPS-1 mutant, like that of the wild-type protein, was markedly reduced on culture of the corresponding cells with CHO-Ras-CD47 cells (Fig. 6B ).
Tyrosine phosphorylation thus appeared dispensable for CD47-induced down- (Fig. 6C) . In contrast, MG132, a reversible peptide aldehyde which blocks proteasomal activity, substantially attenuated the effect of CD47 (Fig. 6C) . None of these reagents affected the expression of SHPS-1 in CHO-SHPS-1-WT cells cocultured with CHO-Ras cells (Fig. 6C) . These results suggest that CD47 binding induces the degradation of SHPS-1 by the proteasome.
CD47-SHPS-1 Interaction Regulates Tyrosine Phosphorylation of FAK-FAK plays an important role in cell migration (38, 39) and is regulated by SHP-2 (22, 23, 40). To investigate further the molecular basis of the regulation of cell
migration by CD47-SHPS-1 interaction, we determined whether this interaction affects the tyrosine phosphorylation of FAK. As expected, the amount of SHPS-1 bound to SHP-2 markedly decreased on exposure to CHO-Ras-CD47 cells (Fig. 7A ). (B) Migration assays were performed in the presence of a mAb to SHPS-1 (10 mg/ml) or control rat IgG (10 mg/ml), each in the absence (upper panels) or presence (lower panels) of goat antibodies to rat IgG (100 mg/ml). Data are means ± SE of triplicate determinations from three independent experiments. *P < 0.05, **P < 0.01 versus corresponding control value. 
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